Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 8, 2015 (11 years ago)

TRI-EST Lozenges

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Penicillin Cross Contamination: potentially contaminated with penicillin

Cause type: Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it. All cross-contamination recalls.

What was recalled

TRI-EST Lozenges, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY

Recalling firm
Life Science Pharmacy Inc
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0502-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Life Science Pharmacy Inc

All 2015 recalls
Class II · Moderate risk

METHYLFOLATE Capsules

Penicillin Cross Contamination: potentially contaminated with penicillin

Terminated Cross-contamination Life Science Pharmacy Inc D-0505-2016

Other cross-contamination recalls from 2015

All cross-contamination recalls
Class II · Moderate risk

Mupirocin Calcium Cream

Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.

Terminated Cross-contamination GlaxoSmithKline, LLC. NDC 66993-942-15 D-1362-2015
Class II · Moderate risk

Bactroban Cream

Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.

Terminated Cross-contamination GlaxoSmithKline, LLC. NDC 0029-1527-22 D-1361-2015
Class II · Moderate risk

Bactroban Ointment

Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.

Terminated Cross-contamination GlaxoSmithKline, LLC. NDC 0029-1525-44 D-1360-2015